Is Summit Therapeutics Inc (SMMT) a Loser in the Healthcare Sector?

Summit Therapeutics Inc (SMMT) is near the middle in its sector according to InvestorsObserver. SMMT gets an overall rating of 43. That means it scores higher than 43% of stocks. Summit Therapeutics Inc gets a 34 rank in the Healthcare sector. Healthcare is number 4 out of 11 sectors.

SMMT has an Overall Score of 43. Find out what this means to you and get the rest of the rankings on SMMT!

See Full SMMT Report

What do These Ratings Mean?

Analyzing stocks can be hard. There are tons of numbers and ratios, and it can be hard to remember what they all mean and what counts as “good” for a given value. InvestorsObserver ranks stocks on eight different metrics. We percentile rank most of our scores to make it easy for investors to understand. A score of 43 means the stock is more attractive than 43 percent of stocks. These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Summit Therapeutics Inc Stock Today?

Summit Therapeutics Inc (SMMT) stock is down -3.9% while the S&P 500 is up 0.3% as of 10:39 AM on Tuesday, Nov 7. SMMT has fallen -$0.09 from the previous closing price of $2.18 on volume of 563,262 shares. Over the past year the S&P 500 is higher by 15.03% while SMMT is up 100.00%. SMMT lost -$1.70 per share the over the last 12 months. Click Here to get the full Stock Report for Summit Therapeutics Inc stock.